If clearance is low then less drug is metabolized per unit time and extraction will be low
Protocol: Sermorelin: 200-300 mcg Ipamorelin: 200-300 mcg Combined injection, usually at bedtime Notes: Sermorelin has a shorter half-life than CJC-1295, creating more discrete GH pulses
If you need a concrete product example, Peptide Warehouse USA lists a CJC-1295 (NO-DAC) + Ipamorelin Blend for research catalog purposes, which is relevant when protocol design involves combined peptide systems rather than ipamorelin alone
2X Blend: Tesamorelin 10mg + Ipamorelin 2mg Strength: 12 mg CAS: Tesamorelin: 218949-48-5 / Ipamorelin: 170851-70-4 Chemical Formula: Tesamorelin: C221H366N72O67S Ipamorelin: C38H49N9O5 Molecular weight: Tesamorelin: CHNOS Ipamorelin: CHNO Peptide Sequence: Tesamorelin: 5136 g/mol Ipamorelin: 711.9 g/mol Synonyms: Tesamorelin: Trans-3-hexenoyl-Tyr Ala Asp Ala Ile Phe Thr Asn Ser Tyr Arg Lys Val Leu Gly Gln Leu Ser Ala Arg Lys Leu Leu Gln Asp Ile Met Ser Arg Gln Gln Gly Glu Ser Asn Gln Glu Arg Gly Ala Arg Ala Arg Leu NH2 Ipamorelin: Aib-His-D-2Nal-D-Phe-Lys-NH Storage: Store 28 C (20 C long-term)
Direct clinician access throughout your treatment Tesamorelin/Ipamorelin stimulates natural growth hormone production, leading to increased muscle mass, fat loss, and improved physical performance
Side effect Some possible side effects of IGF-1 LR3 may include the following: muscle and joint pain, nausea, headaches, hypoglycemia (usually when IGF-1 LR3 is administered in continuous high doses) and may be associated with increased risk of developing some cancers
